Epstein Secrets

ermanent residency rights because of the changes in Russia's immigration laws made in 2019, the lawyer said." Also reporting are Ffloomberg (10/22, Meyer, 4.73M), the Daily Caller (10/22, 716K), the Washington Timec (10/22, Blake, 492K), Reuterc (10/22), and CNN (10/22, Ilyushina, 83.16M). Treasury D

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

o reporting are Bloomberg <https://www.bloomberg.corn/news/articles/2020-10-22/russia-gives-nsa-whistle-blower-snowden-permanent- residency> (10/22, Meyer, 4.73M), the Daily Caller <https://dailycallencorn/2020/10/22/edward-snowden-russia- permanent-residency/> (10/22, 716K), the Washington Times <http

63> (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health." The drug

permanent residency rights because of the changes in Russia's immigration laws made in 2019, the lawyer said." Also reporting are Bloomberg (10/22, Meyer, 4.73M), the Daily Caller (10/22, 716K), the Washington Times (10/22, Blake, 492K), Reuters (10/22), and CNN (10/22, Ilyushina, 83.16M). EFTA00148

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug